Ardaman Shergill, Michael Cecchini, Gerald W. Prager, Stacey A. Cohen, Akihito Kawazoe, Stephanie Wu, Kunal Desai, Martha Raluca Neagu Aristide, Apurvasena Parikh, Athanasios Vasilopoulos, Yunxia Sui, Yu Sunakawa. "A phase 2 randomized study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with standard of care (SOC) in patients with metastatic colorectal cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps255